Dasabuvir/ombitasvir/paritaprevir/ritonavirAlanine aminotransferase elevation and drug resistance: 4 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2019年 / 1739卷 / 1期
关键词：
D O I：
10.1007/s40278-019-57749-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：109 / 109
相关论文
共 50 条
  • [31] Drug-Drug Interaction of Omeprazole With the HCV Direct-Acting Antiviral Agents Paritaprevir/Ritonavir and Ombitasvir With and Without Dasabuvir
    Polepally, Akshanth R.
    Dutta, Sandeep
    Hu, Beibei
    Podsadecki, Thomas J.
    Awni, Walid M.
    Menon, Rajeev M.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (04): : 269 - 277
  • [32] Paritaprevir/ritonavir/ombitasvir plus dasabuvir plus ribavirin therapy and inhibition of the anticoagulant effect of warfarin: a case report
    Puglisi, G. M.
    Smith, S. M.
    Jankovich, R. D.
    Ashby, C. R.
    Jodlowski, T. Z.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (01) : 115 - 118
  • [33] Ombitasvir/paritaprevir/ritonavirOff label use and virological resistance: case report
    Reactions Weekly, 2018, 1707 (1) : 216 - 216
  • [34] ParacetamolAspartate aminotransferase elevation, drug overdose and dosing error: 3 case reports
    Reactions Weekly, 2023, 1976 (1) : 274 - 274
  • [35] Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir
    Menon, Rajeev M.
    Badri, Prajakta S.
    Wang, Tianli
    Polepally, Akshanth R.
    Zha, Jiuhong
    Khatri, Amit
    Wang, Haoyu
    Hu, Beibei
    Coakley, Eoin P.
    Podsadecki, Thomas J.
    Awni, Walid M.
    Dutta, Sandeep
    JOURNAL OF HEPATOLOGY, 2015, 63 (01) : 20 - 29
  • [36] Calcium channel antagonists/ombitasvir/paritaprevir/ritonavirPeripheral oedema and pulmonary oedema: 2 case reports
    Reactions Weekly, 2018, 1711 (1) : 65 - 65
  • [37] Ombitasvir/paritaprevir/ritonavirFatal liver failure, hepatic encephalopathy and variceal bleeding: 3 case reports
    Reactions Weekly, 2018, 1695 (1) : 288 - 288
  • [38] COMPARISON OF FREQUENCIES OF DRUG-DRUG INTERACTIONS BETWEEN SOFOSBUVIR/LEDIPASVIR AND OMBITASVIR/DASABUVIR/PARITAPREVIR/RITONAVIR ± RIBAVIRIN AMONG HIV/HCV COINFECTED PATIENTS
    Schriever, C.
    Ahmed, A.
    Delehanty, K. R.
    Yager, J.
    Farrow, G.
    Kashtan, R.
    Lodise, T.
    Patel, N.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S801 - S801
  • [39] Mechanisms and Predictions of Drug-Drug Interactions of the Hepatitis C Virus Three Direct-Acting Antiviral Regimen: Paritaprevir/Ritonavir, Ombitasvir, and Dasabuvir
    Shebley, Mohamad
    Liu, Jinrong
    Kavetskaia, Olga
    Sydor, Jens
    de Morais, Sonia M.
    Fischer, Volker
    Nijsen, Marjoleen J. M. A.
    Bow, Daniel A. J.
    DRUG METABOLISM AND DISPOSITION, 2017, 45 (07) : 755 - 764
  • [40] Evaluation of Drug-Drug Interactions Between Hepatitis C Antiviral Agents Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and HIV-1 Protease Inhibitors
    Khatri, Amit
    Dutta, Sandeep
    Wang, Haoyu
    Podsadecki, Thomas
    Trinh, Roger
    Awni, Walid
    Menon, Rajeev
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (08) : 972 - 979
12345